What is Guggenheim's price target for RAPT?

Guggenheim's latest stated price target for RAPT Therapeutics Inc. (RAPT) is $70, from its action on Oct 27, 2025.

What is Guggenheim's rating on RAPT?

Guggenheim rates RAPT Buy, a bullish rating, as of Oct 27, 2025.

When did Guggenheim last change its view on RAPT?

On Oct 27, 2025, Guggenheim starts coverage at Buy, price target $70.

Guggenheim RAPT price target and rating history

RAPT Therapeutics Inc. (RAPT) · Health Care

Guggenheim rates RAPT Therapeutics Inc. (RAPT) Buy with a $70 price target, as of its latest action on Oct 27, 2025. It has published 3 rating actions on RAPT since January 2023, including 0 upgrades and 1 downgrade.

Current rating: Buy
Price target: $70
Median target, all firms: Too few
Actions on RAPT: 3

Guggenheim price target on RAPT

Guggenheim price target on RAPT, each point a stated target, January 2023 to October 2025.

Every Guggenheim rating on RAPT

Oct 27, 2025
InitiateGuggenheim starts coverage at Buy, price target $70
May 10, 2024
DowngradeGuggenheim downgrades to Neutral from Buy
Jan 4, 2023
InitiateGuggenheim starts coverage at Buy, price target $55

Questions about Guggenheim and RAPT

What is Guggenheim's price target for RAPT?: Guggenheim's latest stated price target for RAPT Therapeutics Inc. (RAPT) is $70, from its action on Oct 27, 2025.
What is Guggenheim's rating on RAPT?: Guggenheim rates RAPT Buy, a bullish rating, as of Oct 27, 2025.
When did Guggenheim last change its view on RAPT?: On Oct 27, 2025, Guggenheim starts coverage at Buy, price target $70.

More RAPT rating histories

All Guggenheim ratings RAPT news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.